Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Total Debt (2021 - 2025)

Precision Biosciences (DTIL) has disclosed Total Debt for 4 consecutive years, with $22.4 million as the latest value for Q4 2025.

  • Quarterly Total Debt changed 0.37% to $22.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.4 million through Dec 2025, changed 0.37% year-over-year, with the annual reading at $22.4 million for FY2025, 0.37% changed from the prior year.
  • Total Debt for Q4 2025 was $22.4 million at Precision Biosciences, roughly flat from $22.4 million in the prior quarter.
  • The five-year high for Total Debt was $22.5 million in Q2 2024, with the low at $2.4 million in Q2 2021.
  • Average Total Debt over 4 years is $19.3 million, with a median of $22.4 million recorded in 2025.
  • The sharpest move saw Total Debt rose 0.79% in 2024, then dropped 0.62% in 2025.
  • Over 4 years, Total Debt stood at $2.5 million in 2021, then soared by 813.28% to $22.4 million in 2023, then fell by 0.41% to $22.3 million in 2024, then rose by 0.37% to $22.4 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $22.4 million, $22.4 million, and $22.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.